Quantum BioPharma Ltd. (QNTM) News
Track canonical SquawkNews coverage tagged to QNTM, Quantum BioPharma Ltd.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
QNTM equity, liquidity strengthened as FDA approves Lucid-MS trial
Quantum BioPharma says it strengthens equity and liquidity in Q2 2026 following FDA approval of Lucid-MS for a pivotal Phase 2 clinical trial.
EQUITY | Aug 14, 2026, 11:00 AM UTC
M
QNTM Advances MS Therapy
Quantum BioPharma Ltd. is advancing an innovative, first-in-class, patented MS therapy
EQUITY | Jun 25, 2026, 12:30 PM UTC
M
QNTM Developing MS Treatment
Quantum BioPharma Ltd. is developing a patented, first-in-class MS treatment that offers a different approach
EQUITY | Jun 23, 2026, 12:31 PM UTC